EcoR1 Capital »

Proqr Thrapeutics N V shs euro shares owned by EcoR1 Capital

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by EcoR1 Capital from 13F filings

Historical chart of EcoR1 Capital investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by EcoR1 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by EcoR1 Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.9M 3.0M 1.98
2023-09-30 $3.9M 3.0M 1.30
2023-06-30 $4.8M 3.0M 1.62
2023-03-31 $6.2M 2.9M 2.13
2018-12-31 $174k 11k 15.79

More positions owned by EcoR1 Capital

Apellis Pharmaceuticals (APLS)
Mirati Therapeutics
Prothena Corp SHS (PRTA)
Arvinas Ord (ARVN)
Galapagos Nv Spon Adr (GLPG)
ACADIA Pharmaceuticals (ACAD)
Anaptysbio Inc Common (ANAB)
Zymeworks Del (ZYME)
Tango Therapeutics (TNGX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Argenx Se Sponsored Adr (ARGX)
Xencor (XNCR)
Kura Oncology (KURA)
Sarepta Therapeutics (SRPT)
Crinetics Pharmaceuticals In (CRNX)

View all positions for EcoR1 Capital

Top funds holding Proqr Thrapeutics N V shs euro

Privium Fund Management B.V.
EcoR1 Capital
M28 Capital Management
DAFNA Capital Management
Ikarian Capital
Millennium Management
Deutsche Bank Aktiengesellschaft
Monaco Asset Management SAM
Two Sigma Advisers
Franklin Street Advisors
Squarepoint Ops
Citadel Advisors
Two Sigma Investments
Bank of America Corporation
Virtu Financial

View all funds holding Proqr Thrapeutics N V shs euro